Comera Life Sciences Holdings Inc
Change company Symbol lookup
Select an option...
CMRA Comera Life Sciences Holdings Inc
JNJ Johnson & Johnson
AVGO Broadcom Inc
GILD Gilead Sciences Inc
LLY Eli Lilly and Co
ABBV Abbvie Inc
CIEN Ciena Corp
TEAM Atlassian Corp
MRO Marathon Oil Corp
TRGP Targa Resources Corp
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology |
Company profile

Comera Life Sciences Holdings, Inc. is a pre-clinical biotechnology company. The Company is engaged in developing a new generation of bio-innovative biologic medicines to improve patient access, safety, and convenience. Its proprietary formulation platform, SQore, is designed to transform intravenous (IV) biologics into subcutaneous (SQ) versions that patients can self-administer in a single dose. The platform optimizes current versions of subcutaneous biologics and produce biosimilar versions of existing subcutaneous products. It has the potential for broad applications in therapeutic areas dependent on protein-based biologic treatments. The SQore platform includes proprietary structural calculations combined with analytical measurements to guide the selection of excipients for a given protein. The Company’s product programs: CLS-001, a preclinical stage biobetter for Crohn’s and Ulcerative Colitis disease, and CLS-002, a preclinical stage biobetter for various oncology indications.

Price
Delayed
$1.46
Day's Change
-0.045 (-3.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.46
Day's Low
1.46
Volume
(Light)

Today's volume of 335 shares is on pace to be much lighter than CMRA's 10-day average volume of 21,683 shares.

335

Display:

Providers:

UpdateCancel
6 providers
November 17, 2022
November 10, 2022
November 09, 2022
October 18, 2022
October 04, 2022

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.